Form 4: Confluent Director Neha Narkhede Exercises Options and Sells Shares Under 10b5-1 Plan

Confluent, Inc. Director Neha Narkhede reported the exercise of stock options and the subsequent sale of 20,000 Class A Common Stock shares for approximately $456,400, executed under a pre-arranged 10b5-1 trading plan.

Summary

• Neha Narkhede, a Director of Confluent, Inc. (CFLT), reported transactions on June 2, 2025, involving the exercise of stock options and the sale of common stock.
• Ms. Narkhede exercised options to acquire 20,000 shares of Class B Common Stock at an exercise price of $2.24 per share.
• Concurrently, she converted 20,000 shares of Class B Common Stock into an equal number of Class A Common Stock shares.
• Following the conversion, she sold 20,000 shares of Class A Common Stock at an average price of $22.82 per share, with individual sale prices ranging from $22.13 to $23.06.
• These transactions were conducted pursuant to a Rule 10b5-1 trading plan that was adopted on September 13, 2024.
• After these reported transactions, Ms. Narkhede directly holds 20,247 shares of Class A Common Stock and 763,802 shares of Class B Common Stock.
• Additionally, she indirectly holds 1,787 shares of Class A Common Stock through a trust.

Sentiment

Score: 5

Explanation: The sentiment is neutral to slightly negative. While the sale by a director could be perceived negatively, the fact that it was executed under a pre-arranged 10b5-1 plan mitigates concerns about opportunistic selling, making it a routine liquidity event rather than a strong signal of negative outlook.

Positives

• The sale was conducted under a pre-arranged Rule 10b5-1 trading plan, which indicates the transaction was scheduled in advance and not based on immediate, non-public information, reducing concerns about opportunistic insider selling.

Negatives

• A director's sale of shares, even under a 10b5-1 plan, can sometimes be perceived by investors as a lack of confidence or a move to diversify personal holdings, potentially exerting minor downward pressure on stock sentiment.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic outlook.

Industry Context

This filing is a routine insider transaction disclosure and does not provide specific insights into broader industry trends. However, insider trading activity, even under 10b5-1 plans, is closely watched by the market as a signal of management's perspective on the company's valuation and future prospects within its industry.

Related Party Transactions

• The reported transactions involve a director of Confluent, Inc. (Neha Narkhede) exercising stock options and selling company shares, which are considered related party transactions due to her insider status.

Stakeholder Impact

• Shareholders: The sale of shares by a director could be interpreted by some shareholders as a signal, though the 10b5-1 plan reduces the speculative impact. It represents a minor dilution of direct insider ownership relative to total outstanding shares.
• Employees: No direct impact on employees is indicated by this filing.

Key Dates

Keywords

Confluent Inc., CFLT, Neha Narkhede, SEC Form 4, Insider Trading, Stock Option Exercise, Share Sale, 10b5-1 Plan, Class A Common Stock, Class B Common Stock, Director Transactions